TRANSPLANTATION PROCEEDINGS, vol.43, no.3, pp.805-808, 2011 (Journal Indexed in SCI)
Article / Article
Science Citation Index Expanded, Scopus
Aim. Anti-donor antibodies, denoted as "panel-reactive antibodies" (PRAs), are one of the most important factors influencing graft survival after renal transplantation. PRA is generally analyzed with enzyme-linked immunosorbent assay or flow cytometry (FC), which identify the HLA antigen specific for the preformed antibody.